Document is current
Any future updates will be listed below
-
Authors
Barbosa, Daniel A. N. http://orcid.org/0000-0001-7272-1446
Gattas, Sandra
Salgado, Juliana S.
Kuijper, Fiene Marie
Wang, Allan R. http://orcid.org/0000-0002-6622-1610
Huang, Yuhao
Kakusa, Bina
Leuze, Christoph http://orcid.org/0000-0003-4564-8014
Luczak, Artur http://orcid.org/0000-0002-4929-5781
Rapp, Paul
Malenka, Robert C. http://orcid.org/0000-0002-5428-5211
Hermes, Dora
Miller, Kai J.
Heifets, Boris D. http://orcid.org/0000-0003-1474-0379
Bohon, Cara
McNab, Jennifer A. http://orcid.org/0000-0002-1763-0792
Halpern, Casey H. http://orcid.org/0000-0003-3907-216X
- License Information
-
More Information
Article History
Received: 31 January 2022
Accepted: 20 July 2023
First Online: 30 August 2023
Competing interests
: C.H.H. receives consulting and speaking honoraria from Boston Scientific and Insightec. C.H.H, D.A.N.B., S.G. and Y.H. have patents owned by Stanford University related to sensing and brain stimulation for the treatment of neuropsychiatric disorders: USPTO serial number: 63/170,404 and 63/220,432; international publication number: WO 2022/212891 A1 (international publication date: 6 October 2022). C.H.H., D.A.N.B. and J.A.M. have patents related to using tractography for circuit-based brain stimulation: USPTO serial number: 63/210,472; international publication number: WO 2022/266000 (international publication date: 22 December 2022). P.R. declares that the opinions and assertions contained in this manuscript do not necessarily reflect the official policy or position of the Uniformed Services University, the Department of Defense or the Henry M. Jackson Foundation for the Advancement of Military medicine. B.D.H. is on the scientific advisory boards of Osmind and Journey Clinical and is a consultant for Clairvoyant Therapeutics and Vine Ventures. The other authors declare no competing interests.
